Clinical information, hepatic ultrasonography, and serum alpha-fetoprotein (AFP) monitoring at 6–12 month intervals are used to diagnose HCC, although neither of these methods is adequate for detecting extremely tiny (2 cm) HCC tumors. The gene discussed is AFP; the disease is hepatocellular carcinoma.